Skipping doses could cut cancer drug costs without losing effect
Disease control
Recruiting now
This study tests whether taking cabozantinib in a pattern that skips some days can keep the same drug levels in the body as the standard daily dose. It involves 34 adults with advanced kidney cancer who are already on a stable dose. Participants will try both the standard and the…
Phase: PHASE2 • Sponsor: dr. Tom van der Hulle • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC